China Architectural Engineering, Inc (NASDAQ:CAEI) Is The Most Active On NASDAQ During Morning Trading Hours

Dallas, TX– PennyStockMoneyTrain.com is pleased to alert investors of stocks on the move.

China Architectural Engineering, Inc (NASDAQ:CAEI) is surging on a high volume in the early morning trade hours. The stock moved up 17.0% to $2.75 and traded on a high volume of 1.26 million shares compared to total average daily volume of 419k shares Today (August 05, 2009), China Architectural Engineering, Inc Wins New Government Contracts Worth $11.2 Million. China Architectural Engineering, Inc specialize in high-end curtain wall systems (including glass, stone and metal curtain walls), roofing systems, steel construction systems, eco-energy saving building conservation systems and related products, for public works and commercial real estate projects.  

Generex Biotechnology Corporation (NASDAQ:GNBT) is one of the top gainer among NASDAQ. The stock increased over 3.1% to $0.691 on a low traded volume of 1.08 million shares compared to total average daily volume of 7.16 million shares. The 52 week range of the stock is $1.14 and $0.08. Today (August 05, 2009), Generex Biotechnology Corporation announced publication of pre-clinical studies conducted to identify vaccine peptides for the potentially pandemic H5N1 avian influenza virus. Generex Biotechnology Corporation is engaged in the research, development and commercialization of drug delivery systems and technologies. The Company focuses on its technology for the administration of formulations of large molecule drugs to the oral (buccal) cavity using a hand-held aerosol applicator.

Dynavax Technologies Corporation (NASDAQ:DVAX) is currently trading at $2.01. The stock soared over 9.7% on 921k shares. On August 04, 2009, Dynavax Technologies Corporation announced that it has met with the U.S. Food and Drug Administration (FDA) to discuss its plans to resume development of HEPLISAVTM, the Company's Phase 3 investigational hepatitis B vaccine. Dynavax Technologies Corporation is a biopharmaceutical company that discovers and develops a pipeline of Toll-like Receptor (TLR) product candidates. The Company's product candidates include HEPLISAV, a hepatitis B vaccine; SD-101, a Phase Ib hepatitis C therapy; DV-601, a Phase Ib hepatitis B therapy; Universal Flu vaccine, a preclinical vaccine under a supply and option agreement with Novartis.

Penny Stock Money Train alerts its members on stocks that could generate higher than average returns. These include stocks with huge volume, penny stocks that are moving to the upside quickly, penny stocks with buy signals and companies with news. Our alerts are well known for producing incredible results in a short amount of time and our members have made outstanding profits of over 100%.

ABOUT Penny Stock Money Train

PennyStockMoneyTrain.com is a leading stock web site that provides free alerts on stocks that are poised to make big gains. Penny Stock Money Train also tracks small cap penny stocks that could be on the brink of a massive breakout. To feature a company on our web site please contact us at

Penny Stock Money Train is an independent electronic publication that provides information on selected publicly traded companies. Penny Stock Money Train is not a registered investment advisor or broker-dealer. Penny Stock Money Train affiliates, officers, directors and employees may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.